Mayana Bsoul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mayana Bsoul has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Amitabh Pandey
Cardiology Department, Heart and Vascular Institute, Tulane University School of Medicine (Y.L., C.L., G.B., C.M., Y.C., H.Y., M.B., Y.J., A.H., C.Z., A.P., O.K., H.F., N.M.).
2 shared publications- Christian Massad
Cardiology Department, Heart and Vascular Institute, Tulane University School of Medicine (Y.L., C.L., G.B., C.M., Y.C., H.Y., M.B., Y.J., A.H., C.Z., A.P., O.K., H.F., N.M.).
2 shared publications - Ghassan Bidaoui
Cardiology Department, Heart and Vascular Institute, Tulane University School of Medicine (Y.L., C.L., G.B., C.M., Y.C., H.Y., M.B., Y.J., A.H., C.Z., A.P., O.K., H.F., N.M.).
2 shared publications Hadi Younes
Cardiology Department, Heart and Vascular Institute, Tulane University School of Medicine (Y.L., C.L., G.B., C.M., Y.C., H.Y., M.B., Y.J., A.H., C.Z., A.P., O.K., H.F., N.M.).
2 shared publications- Nassir F. Marrouche
Tulane University
2 shared publications - Abboud Hassan
Cardiology Department, Heart and Vascular Institute, Tulane University School of Medicine (Y.L., C.L., G.B., C.M., Y.C., H.Y., M.B., Y.J., A.H., C.Z., A.P., O.K., H.F., N.M.).
1 shared publication
Latest Publications
- 1 November 2026
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 19 (11)
Reclassifying Single Lead Sinus Rhythm ECGs for Improved AF Recurrence Detection With Deep Learning
BACKGROUND: Atrial fibrillation (AF) remains a common outcome after catheter ablation, with recurrence observed in up to 50% of patients within 5 years. Despite extensive research, challenges remain in optimizing observation and prediction windows for AF recurrence assessment. Therefore, we developed and validated a novel deep learning model that reclassifies sinus rhythm based on past and future AF events using single-lead ECG strips from handheld devices. METHODS: Of the 558 participants, 308 with no documented recurrence during study follow-up contributed Benign Sinus strips, while 250 with documented recurrence contributed sinus rhythm strips recorded within ±3 days of an AF event, defined as Severe Sinus strips. Both clinical feature-based models and a deep learning model were used to classify these ECGs according to their proximity to AF recurrence events. Performance was evaluated using area under the receiver operating characteristic curve, accuracy, sensitivity, specificity, and F1-score. RESULTS: The strip-level pretrained deep learning model achieved an area under the receiver operating characteristic curve of 0.86, with sensitivity of 0.79, and specificity of 0.76. The complementary participant-level clinical feature-based Random Forest benchmark achieved an area under the receiver operating characteristic curve of 0.71, sensitivity of 0.58, and specificity of 0.69. Feature-based analyses identified associations involving heart-rate variability, mean R–R interval, female sex, left atrial volume, and mean P-wave duration. CONCLUSIONS: Our dynamic deep learning model reclassifies 30-second single-lead sinus rhythm ECGs based on AF events within ±3 days, transforming a brief ECG snapshot into a summarized indicator of short-term AF risk.
- 1 November 2026
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 19 (11)
Reclassifying Single Lead Sinus Rhythm ECGs for Improved AF Recurrence Detection With Deep Learning
BACKGROUND: Atrial fibrillation (AF) remains a common outcome after catheter ablation, with recurrence observed in up to 50% of patients within 5 years. Despite extensive research, challenges remain in optimizing observation and prediction windows for AF recurrence assessment. Therefore, we developed and validated a novel deep learning model that reclassifies sinus rhythm based on past and future AF events using single-lead ECG strips from handheld devices. METHODS: Of the 558 participants, 308 with no documented recurrence during study follow-up contributed Benign Sinus strips, while 250 with documented recurrence contributed sinus rhythm strips recorded within ±3 days of an AF event, defined as Severe Sinus strips. Both clinical feature-based models and a deep learning model were used to classify these ECGs according to their proximity to AF recurrence events. Performance was evaluated using area under the receiver operating characteristic curve, accuracy, sensitivity, specificity, and F1-score. RESULTS: The strip-level pretrained deep learning model achieved an area under the receiver operating characteristic curve of 0.86, with sensitivity of 0.79, and specificity of 0.76. The complementary participant-level clinical feature-based Random Forest benchmark achieved an area under the receiver operating characteristic curve of 0.71, sensitivity of 0.58, and specificity of 0.69. Feature-based analyses identified associations involving heart-rate variability, mean R–R interval, female sex, left atrial volume, and mean P-wave duration. CONCLUSIONS: Our dynamic deep learning model reclassifies 30-second single-lead sinus rhythm ECGs based on AF events within ±3 days, transforming a brief ECG snapshot into a summarized indicator of short-term AF risk.
- Open Access
- 21 October 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (1) , 36-45
Catheter Ablation Is Associated With a Decrease in Major Adverse Cardiovascular Events and All‐Cause Mortality in Patients With Atrial Fibrillation and Obstructive Sleep Apnea
Introduction: Obstructive sleep apnea (OSA) is a common risk factor for the development and progression of atrial fibrillation (AF). Whether catheter ablation for AF management in patients with coexisting OSA yields survival benefit remains unclear. This study aimed to assess the association of catheter ablation with the incidence of major cardiovascular events (MACE) and all‐cause mortality in patients with AF and OSA. Methods: This was a retrospective cohort study using the TriNetX electronic health record (EHR) database, a global, federated clinical research network aggregating de‐identified patient data from multiple healthcare organizations. The study was conducted using real‐world data collected from community‐based healthcare institutions contributing to the TriNetX network. This multicenter, population‐based dataset includes both primary care and referral center data from across the United States and internationally. Adult patients diagnosed with both AF and OSA between November 2014 and November 2024 were included. Patients entered the study at the time of AF diagnosis, with follow‐up beginning 3 months later. A total of 18,324 patients were included after 1:1 propensity score matching, 9162 who underwent catheter ablation and 9162 who did not. Matching was performed based on over 30 clinical and demographic variables, including age, sex, body mass index, comorbidities, medications (e.g., anticoagulation), CPAP prescription, echocardiographic data, and laboratory values. Participants were selected using a convenience sampling method from those available in the database, with inclusion contingent on complete data and fulfillment of eligibility criteria. Data on refusals or exclusions were not available due to the nature of de‐identified secondary EHR data. Results: Over a median follow‐up of 807 days, 687 MACE events and 438 all‐cause mortality events were recorded. Catheter ablation was associated with a significantly reduced risk of MACE (HR: 0.596, 95% CI: 0.510–0.697) and all‐cause mortality (HR: 0.264, 95% CI: 0.208‐0.335). It was also associated with reduced risk of specific cardiovascular outcomes, including heart failure (HR: 0.376, 95% CI: 0.283–0.501), cerebrovascular disease (HR: 0.492, 95% CI: 0.348–0.696), and cerebral infarction (HR: 0.390, 95% CI: 0.207‐0.733). Conclusion: Catheter ablation in patients with AF and OSA is associated with a reduced risk of MACE, all‐cause mortality, heart failure, and thromboembolic events.
- 21 October 2025
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 37 (1) , 36-45
Open AccessCatheter Ablation Is Associated With a Decrease in Major Adverse Cardiovascular Events and All‐Cause Mortality in Patients With Atrial Fibrillation and Obstructive Sleep Apnea
Introduction: Obstructive sleep apnea (OSA) is a common risk factor for the development and progression of atrial fibrillation (AF). Whether catheter ablation for AF management in patients with coexisting OSA yields survival benefit remains unclear. This study aimed to assess the association of catheter ablation with the incidence of major cardiovascular events (MACE) and all‐cause mortality in patients with AF and OSA. Methods: This was a retrospective cohort study using the TriNetX electronic health record (EHR) database, a global, federated clinical research network aggregating de‐identified patient data from multiple healthcare organizations. The study was conducted using real‐world data collected from community‐based healthcare institutions contributing to the TriNetX network. This multicenter, population‐based dataset includes both primary care and referral center data from across the United States and internationally. Adult patients diagnosed with both AF and OSA between November 2014 and November 2024 were included. Patients entered the study at the time of AF diagnosis, with follow‐up beginning 3 months later. A total of 18,324 patients were included after 1:1 propensity score matching, 9162 who underwent catheter ablation and 9162 who did not. Matching was performed based on over 30 clinical and demographic variables, including age, sex, body mass index, comorbidities, medications (e.g., anticoagulation), CPAP prescription, echocardiographic data, and laboratory values. Participants were selected using a convenience sampling method from those available in the database, with inclusion contingent on complete data and fulfillment of eligibility criteria. Data on refusals or exclusions were not available due to the nature of de‐identified secondary EHR data. Results: Over a median follow‐up of 807 days, 687 MACE events and 438 all‐cause mortality events were recorded. Catheter ablation was associated with a significantly reduced risk of MACE (HR: 0.596, 95% CI: 0.510–0.697) and all‐cause mortality (HR: 0.264, 95% CI: 0.208‐0.335). It was also associated with reduced risk of specific cardiovascular outcomes, including heart failure (HR: 0.376, 95% CI: 0.283–0.501), cerebrovascular disease (HR: 0.492, 95% CI: 0.348–0.696), and cerebral infarction (HR: 0.390, 95% CI: 0.207‐0.733). Conclusion: Catheter ablation in patients with AF and OSA is associated with a reduced risk of MACE, all‐cause mortality, heart failure, and thromboembolic events.